The Enduring Impact of Culture Diagnostics and LFAs in STI Detection and Public Health

Wednesday, April 24th, 2024

Insights from DCN Dx and Biomed Diagnostics for National Public Health Week

In honor of National Public Health Week, we invite you to join us for an insightful audio discussion that explores the critical role of collaborations between public health labs and diagnostic developers in combating the rising tide of sexually transmitted infections (STIs).

Why Listen?

The enduring relevance and reliability of culture diagnostics and LFAs in STI detection
Real-world examples of their effectiveness, such as with Biomed's InPouch® TV and InTray® GC
The importance of user feedback in shaping the development and refinement of these tools
Collaborations between public health labs and diagnostic developers to address STI challenges
Regulatory considerations for STI diagnostic developers

Featured Panelists

Pat Vaughan, Ph.D., Chief Operating Officer at DCN Dx
Sarah Barchard, Senior Clinical Trials Manager at DCN Dx
Brandon Font, Research Scientist and Technical Services Manager at Biomed Diagnostics

Moderators

Mitzi Rettinger, Chief Revenue Officer at DCN Dx
Shubhanga Scott, Account Manager and former Research Scientist at DCN Dx